Janus Henderson Group PLC Inotiv, Inc. Transaction History

Janus Henderson Group PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$9.81 - $26.17 $1.71 Million - $4.55 Million	-173,869 Reduced 23.45%	567,535 $9.56 Million
Q2 2022 Aug 15, 2022	SELL	$9.56 - $25.91 $19,559 - $53,011	-2,046 Reduced 0.28%	741,404 $7.12 Million
Q1 2022 May 16, 2022	BUY	$18.52 - $40.41 $3.56 Million - $7.77 Million	192,286 Added 34.89%	743,450 $19.5 Million
Q4 2021 Feb 14, 2022	BUY	$30.55 - $57.88 $15.2 Million - $28.7 Million	496,694 Added 911.87%	551,164 $23.2 Million
Q3 2021 Nov 16, 2021	BUY	$23.69 - $49.93 $1.29 Million - $2.72 Million	54,470 New	54,470 $1.59 Million

6.73M

154K

57.7K

Ticker NOTV
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 25,594,500
Market Cap $42.5M
Description
Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segme...

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

Stay updated on Janus Henderson Group PLC with notifications on news.